Delivra Health Brands Inc. (TSXV:DHB)
Canada · Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
Sep 2, 2026, 2:48 PM EST
Delivra Health Brands Income Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 11.25 | 13.37 | 12.38 | 9.79 | 8.14 | 7.96 | |
Revenue Growth | -10.74% | 8.01% | 26.42% | 20.30% | 2.30% | 2.24% |
Cost of Revenue | 6.13 | 6.59 | 5.98 | 4.97 | 5.54 | 6.04 |
Gross Profit | 5.12 | 6.78 | 6.4 | 4.82 | 2.6 | 1.92 |
Selling, General & Admin | 5.59 | 6.07 | 5.77 | 4.7 | 6.15 | 8.31 |
Research & Development | - | - | - | - | - | 0.07 |
Operating Expenses | 6.08 | 7.62 | 7.11 | 6.19 | 8.62 | 11.18 |
Operating Income | -0.96 | -0.84 | -0.71 | -1.36 | -6.01 | -9.26 |
Interest Expense | -0.1 | -0.12 | -0.17 | -0.25 | -0.64 | - |
Interest & Investment Income | - | - | - | - | - | 0.04 |
Currency Exchange Gain (Loss) | -0.04 | -0.12 | -0.07 | -0.05 | 0.01 | 0 |
EBT Excluding Unusual Items | -1.1 | -1.08 | -0.94 | -1.67 | -6.64 | -9.22 |
Gain (Loss) on Sale of Investments | - | - | - | -0.02 | 0.49 | -0.6 |
Gain (Loss) on Sale of Assets | - | - | -0.04 | 0.6 | -0.69 | -0.24 |
Asset Writedown | - | - | - | - | -0.4 | -12.11 |
Other Unusual Items | 0.09 | -0.11 | 1.86 | 0.9 | 0.23 | -0.5 |
Pretax Income | -1.01 | -1.19 | 0.88 | -0.18 | -7.01 | -22.67 |
Earnings From Continuing Operations | -1.01 | -1.19 | 0.88 | -0.18 | -7.01 | -22.67 |
Earnings From Discontinued Operations | - | - | - | - | - | -5.87 |
Net Income to Company | -1.01 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 |
Net Income | -1.01 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 |
Net Income to Common | -1.01 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 31 | 31 | 29 | 25 | 25 | 23 |
Shares Outstanding (Diluted) | 31 | 31 | 29 | 25 | 25 | 23 |
Shares Change | -5.46% | 9.44% | 13.08% | - | 11.80% | 5.06% |
EPS (Basic) | -0.03 | -0.04 | 0.03 | -0.01 | -0.28 | -1.26 |
EPS (Diluted) | -0.03 | -0.04 | 0.03 | -0.01 | -0.28 | -1.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -0.33 | -0.75 | 0.76 | -1.09 | -4.45 | -9.68 |
Free Cash Flow Per Share | -0.01 | -0.02 | 0.03 | -0.04 | -0.18 | -0.43 |
Gross Margin | 45.51% | 50.70% | 51.70% | 49.26% | 31.99% | 24.12% |
Operating Margin | -8.52% | -6.29% | -5.74% | -13.92% | -73.87% | -116.39% |
Profit Margin | -8.99% | -8.90% | 7.08% | -1.88% | -86.12% | -358.70% |
Free Cash Flow Margin | -2.89% | -5.64% | 6.11% | -11.11% | -54.69% | -121.67% |
EBITDA | -0.64 | 0.43 | 0.6 | -0.03 | -3.94 | -7.04 |
EBITDA Margin | -5.70% | 3.19% | 4.84% | -0.34% | -48.42% | -88.54% |
D&A For EBITDA | 0.32 | 1.27 | 1.31 | 1.33 | 2.07 | 2.22 |
EBIT | -0.96 | -0.84 | -0.71 | -1.36 | -6.01 | -9.26 |
EBIT Margin | -8.52% | -6.29% | -5.74% | -13.92% | -73.87% | -116.39% |
Revenue as Reported | - | - | - | 9.79 | 8.14 | 7.96 |